Services
Expertises
Resources
Who we are
Closed

Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder

Innovative neurodegeneration research support

Funding available
$ 360,000
Deadline
Unspecified
Location
Canada
Who can apply
Lead Canadian Principal Applicant (Nominated Principal Applicant) who is a member of the Canadian Consortium on Neurodegeneration in Aging (CCNA) in one of these roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant.
See full eligibility

Overview

The Catalyst Grant: COEN Initiative — Pathfinder supports innovative neurodegeneration research on Alzheimer’s disease and related dementia across at least two partner countries, with the Canadian portion offering up to $180,000 per year for 2 years. It is intended for a Lead Canadian Principal Applicant in the Canadian Consortium on Neurodegeneration in Aging.

At a glance

Funding available

Maximum funding
$360,000
Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Conduct research or evaluation activities

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
  • 2SLGBTQI+
Legal structures
All legal structures

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2016
Periods: 1

Eligibility

Who is eligible?

  • Lead Canadian Principal Applicant (Nominated Principal Applicant) who is a member of the Canadian Consortium on Neurodegeneration in Aging (CCNA) in one of these roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant.

Activities funded

  • Research on the latest preventive, diagnostic, and treatment approaches to Alzheimer’s disease and related dementia.
  • High-risk, high-payoff research that encourages new and unconventional approaches and creative solutions to neurodegeneration research challenges.
  • Collaborative research that combines the strengths of centres of excellence in neurodegeneration in at least two partner countries.

How to apply

  • Submit the application to COEN.
  • Canadian applicants must also complete an abbreviated CIHR application and submit it using ResearchNet.
  • Upload the signed signature pages, including the routing slip, in the Print/Upload Signature Pages task in ResearchNet before submitting the application.
  • Complete the mandatory ResearchNet tasks: Identify Participants, Enter Proposal Information, Complete Summary of Research Proposal, Enter Budget Information, Print, sign and upload Signature Pages, Preview Application Materials, and Consent and Submit Application.

Documents Needed

  • Signed signature pages, including the routing slip.
  • A Summary of Research Proposal of one page maximum.
  • An operating budget for the project in Canadian dollars, with a complete justification for funds requested.

Selection criteria

  • CIHR and its partners conduct a relevance review before peer review.
  • Applications deemed relevant will be funded from the top down as far as budgets allow.

Processing and Agreement

  • CIHR and its partners will conduct a relevance review before peer review using application and nominative information.
  • Successful applicants and any other persons working on the project must comply fully with CIHR Funding Policies.
  • Successful applicants will be informed of any special financial requirements prior to the release of funds or when they receive the Authorization for Funding (AFF) document.
  • The Lead Canadian Principal Applicant must submit an electronic Final Report to CIHR.
  • The Nominated Principal Applicant must participate in monitoring, review, and evaluation activities and encourage associates, trainees, and administration to participate as required.

Additional information

  • The initiative is part of the CIHR Dementia Research Strategy and is funded through CIHR’s Roadmap Accelerator Fund.
  • Scientific leadership is provided by the Institute of Aging and the Institute of Neurosciences, Mental Health and Addiction.
  • Applicants are encouraged to use Gender and Sex-Based Analysis in their applications.
  • CIHR encourages researchers to involve citizens where appropriate and to consider Official Languages and Official Language Minority Communities where appropriate.

Contacts

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder Program

What is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?

The Catalyst Grant: COEN Initiative — Pathfinder supports innovative neurodegeneration research on Alzheimer’s disease and related dementia across at least two partner countries, with the Canadian portion offering up to $180,000 per year for 2 years. It is intended for a Lead Canadian Principal Applicant in the Canadian Consortium on Neurodegeneration in Aging.

How much funding can be received?

Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder Funds up to $360,000 of admissible expenses.

Who is eligible for the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program?

To be eligible for the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program, you must: The Lead Canadian Principal Applicant must be a member of the CCNA. The applicant must hold one of these CCNA roles: Nominated Principal Investigator, Principal Investigator, or Co-Applicant. The applicant must consent to sharing nominative information at the time of application.

Who can I contact for more information about the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?

You can contact Canadian Institutes of Health Research (CIHR) by email at laurent.landreville@cihr-irsc.gc.ca or by phone at 613-948-2308.

Where is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder available?

The Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder program is available across Canada.

Is the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder a grant, loan, or tax credit?

Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder is a Grant and Funding

Who are the financial supporters of the Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder?

Catalyst Grant: COEN Initiative — Network of Centres of Excellence in Neurodegeneration (COEN): Pathfinder is funded by Canadian Institutes of Health Research (CIHR)